Trial Profile
A double‑blind, placebo‑controlled, randomized phase II trial to determine the effect of Gemcabene on blood pressure.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Apr 2017
Price :
$35
*
At a glance
- Drugs Gemcabene (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 19 Apr 2017 New trial record